Development and Characterization of Clinically Relevant Tumor Models From Patients With Renal Cell Carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology
Reference46 articles.
1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009
2. The changing natural history of renal cell carcinoma;Pantuck;J Urol,2001
3. Debulking nephrectomy in metastatic renal cancer;Flanigan;Clin Cancer Res,2004
4. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007
5. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lipid Metabolism Pathway and Renal Tumor Therapy;annals of urologic oncology;2023-12-31
2. Combining MTI-31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy;Journal of Applied Genetics;2023-11-07
3. A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma;Frontiers in Oncology;2023-07-11
4. PKM2 allosteric converter: A self-assembly peptide for suppressing renal cell carcinoma and sensitizing chemotherapy;Biomaterials;2023-05
5. Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy;Clinical and Translational Medicine;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3